Previous Close | 3.09 |
1-Year Change | -54.69% |
6-Months Change | 0.32% |
3-Months Change | -9.65% |
Moving Avg (50d) | 2.9348 |
Moving Avg (200d) | 3.4143 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 20.6M |
Beta (3-Years) | 0.7 |
Revenue Growth (ttm) | 33.76% |
Net Profit Margin (ttm) | 27.23% |
Return On Assets (ttm) | 42.97% |
EPS (ttm) | 2.67 |
PE Ratio (ttm) | 1.16 |
Dividend Yield | 56.63% |
Asset Description: | MEI Pharma, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-22 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
3.244 | 3.144 | 3.078 | 2.979 | 2.813 | 2.648 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.